Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolv Technologies Holdings (EVLV) Research & Development (2020 - 2025)

Historic Research & Development for Evolv Technologies Holdings (EVLV) over the last 6 years, with Q3 2025 value amounting to $5.6 million.

  • Evolv Technologies Holdings' Research & Development fell 347.68% to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.6 million, marking a year-over-year decrease of 1544.4%. This contributed to the annual value of $23.4 million for FY2024, which is 419.65% down from last year.
  • Evolv Technologies Holdings' Research & Development amounted to $5.6 million in Q3 2025, which was down 347.68% from $4.7 million recorded in Q2 2025.
  • Evolv Technologies Holdings' Research & Development's 5-year high stood at $6.4 million during Q1 2024, with a 5-year trough of $1.0 million in Q2 2021.
  • In the last 5 years, Evolv Technologies Holdings' Research & Development had a median value of $5.2 million in 2022 and averaged $4.9 million.
  • Its Research & Development has fluctuated over the past 5 years, first plummeted by 3787.57% in 2021, then surged by 31776.5% in 2022.
  • Over the past 5 years, Evolv Technologies Holdings' Research & Development (Quarter) stood at $3.1 million in 2021, then skyrocketed by 57.11% to $4.8 million in 2022, then soared by 31.15% to $6.3 million in 2023, then dropped by 14.49% to $5.4 million in 2024, then rose by 4.04% to $5.6 million in 2025.
  • Its Research & Development was $5.6 million in Q3 2025, compared to $4.7 million in Q2 2025 and $4.9 million in Q1 2025.